Teva enters exclusive biosimilar partnership with Celltrion

07-10-2016

Teva enters exclusive biosimilar partnership with Celltrion

123dartist / shutterstock.com

Teva and South Korean biopharmaceutical company Celltrion have entered into an exclusive partnership to commercialise two of Celltrion’s biosimilars in the US and Canada.


Teva, Celltrion, biosimilar, EMA, partnership

LSIPR